NAD+ IV Therapy for Brain Health
The brain runs on energy. NAD+ is the coenzyme that makes mitochondrial energy production possible, and its levels drop steadily with age. At The Neurogenesis Project, Dr. Sean Orr uses intravenous NAD+ as part of a diagnostic-driven protocol to restore cellular metabolism, support DNA repair, and protect neurons from age-related decline.
What NAD+ Does in the Brain
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a coenzyme found in every living cell. It functions as an electron carrier in the mitochondrial electron transport chain, the process by which cells convert nutrients into adenosine triphosphate (ATP). Without adequate NAD+, mitochondria cannot produce energy efficiently, and cells begin to falter.
The brain is the most energy-demanding organ in the body. It accounts for roughly 2% of total body weight but consumes about 20% of the body’s resting energy output. Neurons require a constant supply of ATP to maintain ion gradients across their membranes, synthesize neurotransmitters, and support synaptic transmission. When NAD+ levels fall, the supply chain behind all of this activity begins to break down.
NAD+ also participates in DNA repair through its role as a substrate for enzymes called PARPs (poly ADP-ribose polymerases), which detect and repair single-strand DNA breaks. It activates sirtuins, a family of proteins that regulate cellular stress responses, mitochondrial biogenesis, and inflammatory signaling. Research published in Cell Metabolism (Imai and Guarente, 2014) demonstrated that sirtuin activity depends directly on NAD+ availability, and that declining NAD+ levels contribute to age-related metabolic dysfunction across tissues, including the brain.
The decline is measurable. Studies suggest that NAD+ levels in human tissue drop by approximately 50% between the ages of 40 and 60. Massudi et al. (2012, PLoS ONE, n=36) documented an age-dependent decrease in NAD+ concentrations in human skin tissue that correlated with increased oxidative DNA damage. In brain tissue, similar declines have been observed in animal models, where reduced NAD+ was associated with impaired mitochondrial function, increased neuroinflammation, and accelerated neuronal loss.
The symptoms that patients notice—slower recall, difficulty concentrating, mental fatigue that worsens through the day, reduced capacity for sustained attention—are downstream consequences of this metabolic shortfall. The neurons are still there, but they lack the fuel to perform at their previous capacity.
Why IV Delivery Matters
NAD+ is available as an oral supplement, and precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are widely sold for daily use. These oral forms have value for long-term maintenance, and Action Potential Supplements offers formulations designed to support NAD+ metabolism as part of an ongoing brain health regimen. But oral bioavailability is limited. NAD+ is a large molecule that is partially degraded in the gut, and the amount that reaches systemic circulation is a fraction of the ingested dose.
Intravenous delivery bypasses the digestive system entirely. The full dose enters the bloodstream directly, producing a rapid and measurable increase in plasma NAD+ concentrations. Grant et al. (2019, Antioxidants & Redox Signaling, n=8) measured a roughly 400% increase in blood NAD+ levels following a single IV infusion, with levels remaining elevated for several hours post-infusion. Oral NR supplementation in the same study produced a smaller and more gradual rise.
At The Neurogenesis Project, NAD+ infusions are administered over two to four hours. The slow drip rate is deliberate. Rapid infusion can cause chest tightness, nausea, and flushing, so Dr. Orr titrates the rate based on each patient’s tolerance. Patients sit comfortably in a clinical infusion suite at our St. Marys, Georgia clinic, and the nursing staff monitors vitals throughout the session.
For patients enrolled in the Intensive Brain Health Program, NAD+ infusions typically run daily over a three-to-five-day treatment block. This approach builds NAD+ stores more effectively than a single session and allows the clinical team to adjust dosing in real time based on patient response.
Who Benefits from NAD+ IV Therapy
NAD+ depletion is a factor in a range of neurological conditions and age-related cognitive changes. The following groups represent the patients who most commonly receive NAD+ infusions as part of their treatment at our clinic.
Age-Related Cognitive Decline
As NAD+ levels fall with age, mitochondrial efficiency drops and neurons lose metabolic capacity. Patients in their 40s through 70s who notice slower processing speed, difficulty with word retrieval, or persistent mental fatigue often have measurably reduced NAD+ availability. Restoring those levels through IV infusion gives neurons the substrate they need to produce energy and maintain repair mechanisms.
Post-Concussive & Traumatic Brain Injury
TBI creates a metabolic crisis in the brain. Injured neurons demand more energy while the mitochondria that supply it are themselves damaged. NAD+ infusions address this mismatch by replenishing the coenzyme pool that mitochondria rely on. For patients recovering from concussion or more severe brain injuries, NAD+ is typically paired with other treatments described on our traumatic brain injury page.
Addiction Recovery
Chronic substance use depletes NAD+ stores and damages mitochondrial function throughout the brain, particularly in the prefrontal cortex and reward circuitry. Patients in early recovery often experience severe fatigue, brain fog, and difficulty with executive function. NAD+ infusions help restore the metabolic baseline these circuits need to begin functioning again. Dr. Orr works with patients in the Rescue from Rehab program to address these deficits alongside other neurological interventions.
Executive Optimization
Not every patient who comes for NAD+ therapy has a diagnosis. Some are executives, physicians, attorneys, and other professionals whose work demands sustained high-level cognitive output. They may have no measurable pathology, but they notice that their mental stamina and processing speed have declined from where they were five or ten years ago. NAD+ infusions, combined with the broader metabolic optimization protocol, help restore the cellular energy economy that underpins peak cognitive function.
Dr. Orr’s Clinical Approach
Dr. Orr does not prescribe NAD+ infusions à la carte. The Neurogenesis Project is not an IV lounge. Every patient who receives NAD+ therapy at our clinic has first completed a diagnostic workup that includes advanced neuroimaging, blood-based biomarker panels, and neurocognitive testing. These results tell Dr. Orr whether mitochondrial dysfunction, NAD+ depletion, or related metabolic deficits are contributing to the patient’s symptoms.
When the data supports it, NAD+ infusions become one part of a multi-modal treatment plan. That plan might also include exosome therapy, mesenchymal stem cells, ketamine for neuroplasticity, neuromodulation, or targeted nutritional interventions. The specific combination depends on what the imaging and lab work reveal. A patient with significant neuroinflammation and low NAD+ markers will receive a different protocol than a patient with intact inflammatory markers but reduced mitochondrial complex I activity.
This diagnostic-first approach is what separates The Neurogenesis Project from clinics that offer NAD+ as a wellness service. Dr. Orr treats the underlying neurology. NAD+ is a tool in that treatment, not the treatment itself.
After the initial treatment block, follow-up testing measures objective changes. Repeat neurocognitive assessments, updated biomarker panels, and in some cases follow-up imaging allow Dr. Orr to track whether the intervention produced measurable improvement and to adjust the protocol accordingly. Patients in the Intensive Brain Health Program receive this follow-up as a standard part of their care.
Related Treatments
Exosome Therapy
Cell-derived vesicles that carry repair signals across the blood-brain barrier. Used alongside NAD+ to target neuroinflammation and promote neural recovery.
Stem Cell Therapy
Mesenchymal stem cells for sustained neural repair and immunomodulation. Often combined with NAD+ infusions in the Intensive Brain Health Program.
Ketamine Therapy
Sub-anesthetic ketamine to promote synaptogenesis and neuroplasticity. Paired with NAD+ when both metabolic and synaptic repair are indicated by diagnostic testing.
Frequently Asked Questions
What is NAD+ and why does the brain need it?+
How is NAD+ administered at The Neurogenesis Project?+
Who is a candidate for NAD+ IV therapy?+
How many NAD+ sessions are typically needed?+
What does NAD+ IV therapy cost?+
Is NAD+ IV therapy FDA-approved?+
Restore Your Brain’s Energy Supply
NAD+ is the molecule your mitochondria depend on to keep neurons firing. If age, injury, or years of metabolic stress have depleted your reserves, a diagnostic workup with Dr. Orr can determine whether IV NAD+ therapy belongs in your treatment plan.